IMMUNOGENESIS, INC.

Profile

Company Names

IMMUNOGENESIS, INC.

Addresses

263 NORTH MAIN ST., APT 417, DOYLESTOWN, PA 18901

2450 HOLCOMBE BLVD, SUITE J, HOUSTON, TX 77021

Phone Numbers

3467720336

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$50,176,110.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-12-18 
$5,749,998.00 
$24,999,999.00 
$19,250,001.00 
Equity 
1
2024-03-18 
$44,426,112.00 
$66,531,095.00 
$22,104,983.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
BARLOW 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOGENESIS, INC.   |  RENUE REAL ESTATE FUND I LP
JENNIFER 
 
BARLOW 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOGENESIS, INC.
JEREMY 
 
BARTON 
EXECUTIVE OFFICER
IMMUNOGENESIS, INC.
THOMAS 
 
BARTON 
DIRECTOR
ASTRAEA, INC.   |  ANTARIS, INC.   |  MYRTELLE INC.   |  IMMUNOGENESIS, INC.   |  ALETHEIA BIOTHERAPEUTICS, LLC
MICHAEL 
 
CURRAN 
DIRECTOR
IMMUNOGENESIS, INC.
MICHAEL 
A. 
CURRAN 
DIRECTOR
IMMUNOGENESIS, INC.
TED 
 
KOUTOUZIS 
DIRECTOR
NEURAL ANALYTICS, INC.   |  CALA HEALTH, INC.   |  IMVAX, INC.   |  EXO IMAGING, INC.   |  ONCORESPONSE INC   |  NOVASIGNAL CORP.   |  IMMUNOGENESIS, INC.
FEDERICA 
 
O-BRIEN 
EXECUTIVE OFFICER
CERVILENZ INC   |  COMPLEXA INC.   |  IMMUNOGENESIS, INC.
FEDERICA 
 
PERICLE 
EXECUTIVE OFFICER
AGILVAX, INC.   |  IMMUNOGENESIS, INC.
ROBERT 
 
STEIN 
DIRECTOR
PROGRESSIVE BOOK CLUB LLC   |  AGENUS INC   |  ASSURANT INC   |  REACTIVECORE, INC.   |  FLAME BIOSCIENCES, INC.   |  IMMUNOGENESIS, INC.   |  ALPHEUS MEDICAL, INC.
ROBERT 
B. 
STEIN 
DIRECTOR
KINEMED INC   |  ATRINSIC, INC.   |  AGENUS INC   |  IMMUNOGENESIS, INC.
CLIFFORD 
 
STOCKS 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  THERACLONE SCIENCES, INC.   |  ONCORESPONSE INC   |  CARDIAC INSIGHT, INC.   |  K2 BIOLABS, LLC   |  IMMUNOGENESIS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-18 
2024-04-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SPARTAN CAPITAL SECURITIES, LLC
146251